Webinar: Minimize Disruption of Your Oncology Trial in the era of COVID-19

Webinar: Minimize Disruption of Your Oncology Trial in the era of COVID-19


Date: Tuesday, June 23, 2020
Time: 12:00-1:00 PM EST
Webinar Title: Minimize Disruption of Your Oncology Trial in the era of COVID-19

Oncology trials always come with their share of complexities and challenges. Since its onset, COVID-19 has had the industry’s undivided attention, with clinical trial professionals adapting clinical trial operational plans to accommodate. From data integrity to participant recruitment and retention, our industry has temporarily reconsidered long held habits. As the world begins to relax restrictions, what are the lessons learned that can catapult us into the next innovation in trial operations for good?

In this webinar, our panel of experts share examples and lessons learned during the COVID-19 window and explore how those lessons can drive meaningful change over the next 12 months including:

• Leveraging technology to maximize risk and quality oversight
• Maximizing the patient experience and patient retention
• Designing trials to collect the data we need
• Managing missing data and redesigning analyses to account for anomalies like COVID

Who should attend?

• Clinical affairs professionals
• Medical affairs professionals
• R&D Heads
• Oncology clinical professionals
• Oncology-focused biotech and pharmaceutical companies
• Clinical trial coordinators and Site Managers

• Moffitt: Cristina Naso
• OncoBay: Dannelle Palmer, VP Clinical Operations
• Veristat, Biometrics
• Veristat, Regulatory


The Latest News & Events


Take Advantage of OncoBay’s Innovative Approach


Submit a Request for Proposal

Submit Proposal

OncoBay is now Kapadi


Once three entities – OncoBay Clinical, Clinscience, and Exom Group s.r.l – now we stand as one, bringing forth a symphony of expertise and seamless operations. To celebrate our unity, we re-brand under the banner of Kapadi, and embark on a new chapter of exceptional service in oncology clinical research.

Kapadi is not just a name; it's a testament to our fusion. It signifies the our standing as a global CRO powerhouse committed to accelerating groundbreaking cancer therapies that uplift patients worldwide. From conceptualizing studies, navigating regulations, and analyzing data, we provide a comprehensive array of services designed to empower your oncology clinical trials.


Visit Kapadi.com


This pop-up will auto-close in 10 seconds.

This will close in 5 seconds